British-Swedish pharmaceutical giant AstraZeneca endured a torrid time in China last year, as it underwent several investigations and saw one…
Read More »National Healthcare Security Administration
A number of major Chinese cities have reported worrisome deficits in their government-run health insurance funds, as rising medical costs…
Read More »China has added dozens of new drugs to its health insurance reimbursement list, signalling support for innovative treatments while keeping…
Read More »